Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd (301126) — Capital Reinvestment Ratio
Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd (301126) has a Capital Reinvestment Ratio of 7.78x as of December 2024, meaning it reinvests 8% of its operating cash flow (CN¥24.04 Million) in capital expenditures (CN¥187.14 Million). See Hunan Dajiaweikang Pharmaceutical Indust free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd Capital Reinvestment Ratio (2019–2024)
This chart tracks Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd's Capital Reinvestment Ratio across 3 annual periods.
Annual Capital Reinvestment Ratio for Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd (2019–2024)
Year-by-year Capital Reinvestment Ratio for Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd from 2019 to 2024. For live market cap and broader valuation context, see Hunan Dajiaweikang Pharmaceutical Indust stock valuation.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 7.78x | CN¥24.04 Million | CN¥187.14 Million | ▼ -6.8% |
| 2023 | 8.36x | CN¥27.13 Million | CN¥226.70 Million | ▲ +3394.0% |
| 2019 | 0.24x | CN¥135.91 Million | CN¥32.50 Million | — |